builderall

3 min read

???



?????On 4 November 2026, Brazil's Official Gazette published ANVISA Normative Instruction (IN) No. 476/2026, updating selected food additive and processing aid authorisations under IN No. 211/2023. The amendment introduces specific uses for nutritional ingredients and powdered whey protein concentrate, while correcting an existing provision concerning infant formula.

For food manufacturers and ingredient suppliers, the significance is not a general expansion of permitted additives. Rather, it is an opportunity to revisit selected formulations, provided that each substance, technological function and intended application meets the applicable regulatory conditions.

New possibilities for nutritional ingredients

In category 22.0, the update authorises specific uses of glycerol (INS 422), citric acid (INS 330) and trisodium citrate (INS 331(iii)) in formulated additive preparations and ingredients supplying vitamins, minerals or other substances for nutritional or physiological purposes.

However, their permissions are not identical. Glycerol can perform several technological functions, but its use in formulated additives is restricted to colour-based preparations. Citric acid has a broader range of authorised applications, while trisodium citrate is permitted solely as an acidity regulator, subject to restrictions on the preparations in which it can be used.

All three are authorised at quantum satis for these uses. Under RDC No. 778/2023, this means the minimum concentration necessary to achieve the intended technological effect, rather than unrestricted addition.

Another relevant development concerns powdered whey protein concentrate in category 01.9. Three phosphates, INS 339(i), 450(i) and 451(i), are now permitted as stabilisers at a maximum of 4,400 mg/kg, expressed as phosphorus, individually or in combination.

This authorisation applies exclusively to powdered whey protein concentrate. It does not extend to whey protein isolate or establish a general phosphate allowance for finished protein supplements or nutritional beverages.

From ingredient to finished product

Permission to use an additive in an ingredient does not automatically authorise its direct addition to a finished food. RDC No. 778/2023 allows additive carry-over only under specific conditions concerning authorisation, maximum levels and technological use.

Importantly, the general carry-over principle does not apply to foods or supplements intended for infants and young children. In these cases, additives used in ingredients must also be permitted in the finished product.

The infant formula amendment illustrates this distinction. ANVISA corrected the wording concerning concentrated mixed tocopherols (INS 307b), authorised as an antioxidant in specified infant formulas at 10 mg/kg or mg/L in the product as consumed. The agency confirms that this is an editorial correction, not a new authorisation for INS 307a or INS 307c, nor an increase in the existing limit.

IN No. 476/2026 entered into force on 4 November 2026, without introducing a general new reformulation deadline. Its immediate relevance lies in reviewing ingredient specifications and development projects against the updated permissions.

Brazil's additive framework is subject to regular review, including changes arising from technical developments and industry applications. For businesses operating in this market, staying informed about these updates can reveal formulation opportunities, clarify restrictions and help anticipate regulatory challenges before they affect product development or market access.






© All rights reserved. All news and diagrams placed on this Web site is made for internal use. Its reproduction or distribution in any form are welcome in case of placing a direct hyperlink to a source. Reproduction or distribution of information which contains FJS International Solutions® as a source is prohibited without the written permission from the FJS International Solutions®. Photos placed on this site are taken from open sources only or purchased.